Company intelligence / Profile preview

INC Research

Raleigh, North Carolina, United States

Ownership: Private
Employees: ~6800
Development stage: Other

Overview

INC Research was a leading global contract research organization (CRO) providing comprehensive Phase I to Phase IV clinical development services to the pharmaceutical and biotechnology industries. The company was recognized for its deep therapeutic expertise in complex areas, particularly oncology and central nervous system (CNS) disorders. Headquartered in Raleigh, North Carolina, it maintained a global footprint with operations in over 100 countries. In 2017, INC Research completed a multi-billion dollar merger of equals with inVentiv Health, creating one of the world's largest clinical and commercial service providers. The combined entity was subsequently rebranded as Syneos Health in early 2018, effectively retiring the INC Research brand.

Industry: Contract Research Organization

Beyond the preview

Go deeper on INC Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INC Research.

Explore the full profile